deltatrials
Completed PHASE4 NCT00411177

Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis

Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis (TURKISH HDF STUDY)

Sponsor: Ercan OK

Conditions End-Stage Renal Disease
Interventions high flux hemodialysis post-dilution on-line hemodiafiltration
Updated 6 times since 2017 Last updated: Sep 6, 2013 Started: Jan 31, 2007 Primary completion: Jan 31, 2010 Completion: Mar 31, 2010

This PHASE4 trial investigates End-Stage Renal Disease and is currently completed. Ercan OK leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 7 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ercan OK
  • Fresenius Medical Care North America
Data source: Ege University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations